marijuana stocks news

FutureWorld’s URVape (FWDG) Provides Shareholder Update

ST. PETERSBURG, FL, Nov. 25, 2014 (GLOBE NEWSWIRE) — FutureWorld (FWDG), a U.S. Diversified Holding Company formed to capitalize on the burgeoning technology markets globally, announces the following letter to its shareholders from URVape subsidiary’s new CEO, Daniel Montgomery:

Dear Shareholders: As the new CEO of URVape, Inc., I would like to introduce myself to all of our FutureWorld shareholders and provide an update on URVape’s current business and events;

As of October 15, 2014 I was hired as URVape’s CEO, based upon my varied business experience: Ranging from International Trade and Finance, to contract negotiation with international and multi-national corporations and governments, to consultation, lobbying and being called as an expert witness. My educational background included engineering, finance, marketing and law.

URVape was started to contribute to the current revolution, which has become an international phenomenon, known as the “Vaping” industry. URVape began test marketing OEM branded, off-the-shelf oil vaporizers, whose design and utility was well received, and which promulgated our first vendor agreement in the state of Colorado.

After studying the marketplace, with more than 466 vendors attempting to reach nicotine consumers, we recognized early on that there were unsupported claims and deficiencies in the products and e-liquids being sold. Product deficiencies were noted in the devices being used in combination with e-liquids, which, together could be producing harmful elements. Consequently, these elements are being inhaled as a result of heating the contents of the e-liquids, thereby producing potentially harmful changes to the initial ingredients. As a result, URVape has dedicated itself to providing products that are free of any substances which, when heated for vaping, could be harmful.

URVape has entered into an exclusive Non-disclosure/Non-compete contract with one of the foremost international vaping products manufacturers. Through our in-house Product Development personnel, and through the hiring of a consultant whose area of expertise is microbiology, specific to cannabis and vaping, we have developed two primary device changes that are being patented. These changes are designed to produce safe devices, built with safe materials, and to exact temperature specifications suited to a variety of e-liquids that we will bring to market.

We are also developing new methods of producing, packaging and flavoring a variety of e-liquids with the intention to provide consumers with happy, healthy and potentially curative products.

URVape’s plans include the installation of its own laboratory along with a “clean room” for production of its products. The goal is to become the market leader of safe vaping materials. To that end, URVape has Trademarked “SafeVape” for use in describing the technologies utilized in bringing both devices and e-liquids to the marketplace.

The E-cigarette, Cannabis and Herbal vaping industry is an ever growing and evolving industry. Business models need to be constantly adjusted and configured based on all moving parts. But we are fortunate to be part of this historical moment in time where consumers around the globe will finally have access to natural plant derivatives to enhance their health and enjoyment without the inherent side effects of synthetic medicines. URVape will be part of that historical moment creating technologies for the delivery of its specialized, researched products.

It is my considerate goal to propel URVape to the forefront of the Vaping Industry, through the introduction of safe, effective products, using our “SafeVape” development technologies. My preliminary cash flow analysis suggests that URVape should be debt free and collecting over $2,000,000 in annual revenues by the end of year one. Future anticipated growth will be exponential.

We are also ramping up for the proposed Spin-Off. We will inform the investors for more detail shortly.

Regards, Daniel Montgomery, CEO –

About URVape

URVape ( is a Florida Corporation, wholly owned by FutureWorld Corp., based in Saint Petersburg, Florida. URVape manufactures, markets, and distributes electronic cigarettes, vaporizers, and accessories under the URVape brand name in the United States. It offers vaporizers and related products through its online store, as well as through the company’s wholesale, distributor, and retail programs. Operating on the idea of open source technology and innovation, the URVape vision is to bring standardized versatility to our customers by offering easily customizable vape pen solutions. URVape supplies avid vape enthusiasts and smokers with a sleek and sophisticated vaporizer that is both affordable and covetable. The Company already plans on adding a loose-leaf herb vape pen, wax vape pen and CBD oil to the mix of offering. The Company is setting the stage for a leading position within the world’s 200 billion dollar tobacco market and the multibillion dollar cannabis industry.

About FutureWorld Corp.

FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a U.S. Diversified Holding Company formed to capitalize on the burgeoning Cannabis markets globally. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products, such as industrial Hemp. FutureWorld, through its subsidiaries such as CB Scientific and HempTech, provides personal and professional THC and CBD test kits, pure CBD oil solutions, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry.

To request further information about FutureWorld, please email us at, log onto our website at or visit us at our Facebook page or on Twitter #futureworldinc.
Safe Harbor & Forward-Looking Statement

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


FutureWorld Corp. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company and its subsidiaries do not grow, distribute or sell marijuana. The company does sell and distribute hemp-based products such as CBD oil.

Media Contact
FutureWorld Corp.
Investor Relations
(727) 474-1816 ext. 103

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Green Cures & Botanical Distribution, Inc. (GRCU) Announces Production Updates for Hollywood Green Botanical Vodka

Green Cures & Botanical Distribution Announces Production Updates for Hollywood Green Botanical…

Tilray Brands, Inc. (TLRY) to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on July 26, 2023

Tilray Brands, Inc. to Announce Fourth Quarter and Fiscal Year 2023 Financial…

Trulieve Cannabis Corp. (TCNNF) Opening Medical Cannabis Dispensary in Apollo Beach, Florida

Trulieve Opening Medical Cannabis Dispensary in Apollo Beach, Florida Trulieve Cannabis Corp.…

Leafbuyer Technologies, Inc. (LBUY) Launches Innovative Advertising Platform for Cannabis Product Companies

Leafbuyer Technologies Launches Innovative Advertising Platform for Cannabis Product Companies Leafbuyer Technologies,…